info@ausbiotech.com.au +61 2 9452 6666 how to order

Australian Biotechnologies is committed to maintaining a strict quality management system that complies with and is regulated by the TGA (Therapeutic Goods Administration), to ensure that customer requirements are met.

Our Quality Policy:

‘Australian Biotechnologies Pty Ltd undertakes to perform all that is necessary to ensure each product or service supplied conforms to approved product specifications and ultimately meets or exceeds customer expectations and regulatory requirements’.

The Australian Biotechnologies Quality System is designed to ensure the systems and practices used on-site and the allografts manufactured are compliant to the Australian Therapeutic Goods Administration (TGA), Code of Good Manufacturing Practice for Therapeutic Goods – Human Blood and Blood Components, Human Tissues and Human Cellular Therapy Products, May 2013. Australian Biotechnologies further commits to continuous quality improvement.